IL17A and arthritic joint disease: Transferring DCs treated with SMAs to mice can significantly reduce the severity of collagen-induced arthritis, which is accompanied by a significant generation of Foxp3+CD4+ Treg cells and/or the production of IL-10, and a reduction in IL-17+ cells in the draining lymph nodes (Lumb et al., 2017).